Market revenue in 2023 | USD 242.1 million |
Market revenue in 2030 | USD 439.3 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Laser |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Laser, Injectables, Other Products |
Key market players worldwide | Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Mölnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, Newmedical, Make Love Not Scars |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scar treatment market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 59.36% in 2023. Horizon Databook has segmented the South Korea scar treatment market based on topical, laser, injectables, other products covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is the 8th largest esthetic market in the world, having the largest count of esthetic procedures per capita globally, with 600+ clinics in Seoul alone. Key market drivers include rise in medical tourism, increasing public awareness about cosmetic procedures, and availability of technologically advanced & user-friendly products.
The advent of new technologies is adding to the scope of adoption of new cosmetic procedures, and cosmetic treatment cost in South Korea is approximately 40% to 80% cheaper than in other countries. Thus, thousands of people travel to the country every year to undergo various surgical and nonsurgical procedures.
Cosmetic regulations in Korea are not very stringent and enable a diverse range of treatment options for scar revision procedures. According to the International Society of Aesthetic Plastic Surgery (ISAPS), on the basis of per capita, South Korea ranks first, with 13.5 cosmetic procedures performed per 1,000 individuals.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea scar treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Korea scar treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account